-
ruplun
- Master | Next Rank: 500 Posts
- Posts: 232
- Joined: Fri Jun 18, 2010 7:09 am
- Thanked: 1 times
- Followed by:2 members
1.While price supports for dairy products will save jobs in the dairy industry, they will also endanger jobs in other food industries. Because price supports will make dairy products more expensive, families will spend a greater portion of their food budgets on dairy products.
The author's argument depends on which of the following premises?
Most consumers would not prefer lower-priced dairy products to other lower-priced food items.
If dairy price supports are implemented, there will be an increase in the number of jobs in the dairy industry.
Consumers would spend more money on other types of food if there were no dairy price supports.
If price supports for other food products were implemented, sales of those products would decline.
The quantity of dairy products sold will decrease if price supports are implemented.
2.Pharmaceutical companies typically charge slightly inflated prices for drugs that have a large customer base and are heavily prescribed by doctors to balance the losses such companies experience from producing "orphan" drugs, drugs that are used by so few patients that they can never be profitable. New federal regulations require pharmaceutical companies to limit the price they charge for any drug to cost plus a predetermined percentage profit.
If the statements above are true, which of the following must also be true?
New pharmaceutical technology has made advances possible; the drugs produced by such technology, however, are too expensive for all but the most wealthy patients.
If pharmaceutical companies do not find another source of income to balance the losses they experience in producing "orphan" drugs, such companies will no longer be able to produce such drugs without compromising overall profits.
Some patients already request generic pharmaceuticals, when they are available, because they are typically less expensive than name-brand pharmaceuticals.
If pharmaceutical companies reduce the costs of producing most drugs, they will be able to earn more profits despite the new law, and thus will be able to balance the losses they experience from the production of "orphan" drugs.
Even though charitable organizations that fund research into the rare diseases treated by "orphan" drugs provide some donations to offset the costs of "orphan" drugs, such donations are declining.
3.As more and more women develop breast cancer, the disease is given more media coverage, which will lead to increased funding for breast cancer research.
Which of the following, if true, offers the LEAST support to the argument above?
Although some breast cancer cases may be inherited, the primary cause of the increased number of cases may prove to be environmental.
In the past five years, several famous women have been stricken with breast cancer and given numerous interviews on the subject.
When a cause receives increased media coverage, philanthropic foundations tend to give that cause added financial support.
As long as a disease is unpublicized, it is unlikely to attract either researchers or funding for research.
In recent years, breast cancer has stricken more women than has any other type of cancer, or even any other disease.
The author's argument depends on which of the following premises?
Most consumers would not prefer lower-priced dairy products to other lower-priced food items.
If dairy price supports are implemented, there will be an increase in the number of jobs in the dairy industry.
Consumers would spend more money on other types of food if there were no dairy price supports.
If price supports for other food products were implemented, sales of those products would decline.
The quantity of dairy products sold will decrease if price supports are implemented.
2.Pharmaceutical companies typically charge slightly inflated prices for drugs that have a large customer base and are heavily prescribed by doctors to balance the losses such companies experience from producing "orphan" drugs, drugs that are used by so few patients that they can never be profitable. New federal regulations require pharmaceutical companies to limit the price they charge for any drug to cost plus a predetermined percentage profit.
If the statements above are true, which of the following must also be true?
New pharmaceutical technology has made advances possible; the drugs produced by such technology, however, are too expensive for all but the most wealthy patients.
If pharmaceutical companies do not find another source of income to balance the losses they experience in producing "orphan" drugs, such companies will no longer be able to produce such drugs without compromising overall profits.
Some patients already request generic pharmaceuticals, when they are available, because they are typically less expensive than name-brand pharmaceuticals.
If pharmaceutical companies reduce the costs of producing most drugs, they will be able to earn more profits despite the new law, and thus will be able to balance the losses they experience from the production of "orphan" drugs.
Even though charitable organizations that fund research into the rare diseases treated by "orphan" drugs provide some donations to offset the costs of "orphan" drugs, such donations are declining.
3.As more and more women develop breast cancer, the disease is given more media coverage, which will lead to increased funding for breast cancer research.
Which of the following, if true, offers the LEAST support to the argument above?
Although some breast cancer cases may be inherited, the primary cause of the increased number of cases may prove to be environmental.
In the past five years, several famous women have been stricken with breast cancer and given numerous interviews on the subject.
When a cause receives increased media coverage, philanthropic foundations tend to give that cause added financial support.
As long as a disease is unpublicized, it is unlikely to attract either researchers or funding for research.
In recent years, breast cancer has stricken more women than has any other type of cancer, or even any other disease.
